Adva-Tec Inc Profile last edited on: 10/31/22
CAGE: 8DAJ5
UEI: KLRTLESCX6A7
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 03
County: Anderson
Congr. District: 03
County: Anderson
Public Profile
Though the firm's public profile and presence appears to be almost nom-existent, NIH was impressed enough to make a $1m straight to Phase II award - not common - to Adva-Tec for the principals of the firm to address development of hormone-free intravaginal products.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 2 | NIH | $1,878,846 | |
| Project Title: Clinical Evaluation of a Compliant, Degradable Ureteral Stent to Reduce Patient Pain and Improve Tolerability | ||||
Key People / Management
Jennifer Cartledge -- President
Donald Crossley
Donald Crossley
Company News
There are no news available.
